Clinical Trials Arena on MSN9d
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP
"Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP" was originally created and published by ...
Aging retinal pigmented epithelium: Omics-based insights into vision decline
A new editorial paper titled "Aging retinal pigmented epithelium: omics-based insights into vision decline" has been ...
Nature4y
Asthma and allergy: The emerging epithelium
In 'Bedside to Bench', Clare M. Lloyd and Sejal Saglani examine how recent human studies are putting the focus on the epithelium as a major contributor to asthma. The findings shift the emphasis ...
FDA gives Glaukos ‘Day 74’ notice for Epioxa NDA to treat keratoconus
Glaukos (GKOS) announced it has received the “Day 74” notification from the U.S. Food and Drug Administration FDA acknowledging the previously ...
Business Wire7d
Luxa Biotechnology Presents Clinical Data from First-in-Human Retinal Pigment Epithelium Cell Therapy Trial for Dry Age-Related Macular Degeneration at the 77th Annual Wills ...
Dry AMD causes diminished vision accompanied by loss of central retinal pigmented epithelium (RPE) cells in individuals aged 55 and older. There are no approved vision-improving treatments for dry ...